| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.32 | 0.04 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |